Vigilance Signal Detection and Management Technology Systems and Associated Services

Descriptions

The SafetyConnect programme is a technology-enabled strategic business change programme. It aims to significantly enhance the UK’s vigilance capability and revolutionise the way it shares and uses information for the greatest public health impact. The programme will achieve this by investing in increased technological capabilities that can better analyse and respond to adverse drug reactions and incidents related to medical devices and blood reported by patients, the healthcare community and manufacturers. This is an integral part of the Agency’s overall ambition and provides a unique opportunity to transform how the Agency monitors and acts on safety insights across the full product lifecycle, through joined up safety vigilance, reporting and information. The MHRA are seeking to procure new systems and associated services to replace its existing specialist signal detection, case management and analytics systems used in its pharmacovigilance and medial product vigilance activities.